News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celltrion, Inc. (068270.KQ) Tumbles on Reports of Probe Into Share Trades


9/16/2013 8:06:31 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Shares in South Korean bio-pharmaceutical firm Celltrion Inc (068270.KQ), which is up for sale, tumbled as much as 14.8 percent on Monday after reports that financial regulators are pursuing its chief executive over suspicious sharemarket trades. Yonhap news agency and Korean broadcaster SBS CNBC said in unsourced reports that regulators had made a preliminary conclusion in the matter regarding Celltrion chief executive Seo Jung-jin at a meeting on Friday.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Yonhap News
Read at Financial Times

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES